Public-registry site landscape for NCT05159778, a Malignant Neoplasm of Breast study sponsored by HiberCell, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05159778 (registry record) |
| Sponsor | HiberCell, Inc. |
| Condition(s) | Malignant Neoplasm of Breast |
| Phase | PHASE2 |
| Listed sites | 16 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05159778 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →